Clinical Trial Update: Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant/adjuvant pembrolizumab combined with chemotherapy for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Non Small Cell Lung Cancer, Neoadjuvant Therapy | Phase 2 | Status: ACTIVE_NOT_RECRUITING